Current Pharmacological Treatment of Dementia

Treatment of Dementia - The Carlat Psychiatry Report (TCPR)

Patients with dementia and their families may express frustration about the limited number of options for improving cognitive symptoms, but they are not without choices. Here we will review a number of pharmacological treatment options for Alzheimer’s disease (AD) and other major types of dementia.

Medications for Treating Alzheimer’s Dementia

The Diagnosis and Treatment of Dementia

While drug companies have been working hard to come up with new options for the treatment of dementia, there have been no new FDA approvals since memantine (Namenda) hit the scene in 2003.

Research Update

Personality May Influence the Risk for Alzheimer’s

It’s commonly known that the risk of developing dementia is related to education level, history of head trauma, family history, and genetics. But could personality also play a role?

SNRIs Likely No Better than SSRIs for Depression

Due to their inhibition of both serotonin and norepinephrine reuptake, the SNRIs venlafaxine (Effexor) and duloxetine (Cymbalta) have been billed as possessing an advantage over SSRIs.